This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glenmark Pharmaceuticals Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: An Insight into the Innovations of Inventor Mohammad Amjed Khan
Introduction: Mohammad Amjed Khan is a notable inventor based in Navi Mumbai, India. His contributions to the field of pharmaceuticals are reflected in his innovative approach to the preparation of vital compounds. With one patent to his name, Khan is recognized for his significant contributions while working at Glenmark Pharmaceuticals Limited.
Latest Patents: Khan's recent patent is titled "Process for the preparation of ivacaftor and solvates thereof." This invention outlines a novel process for the synthesis of ivacaftor, an essential medication used for treating cystic fibrosis. The method described in this patent is anticipated to enhance the availability and efficacy of this important drug.
Career Highlights: Throughout his career, Mohammad Amjed Khan has focused on pharmaceutical research and development. His role at Glenmark Pharmaceuticals Limited allows him to apply his expertise and creativity in an environment that fosters innovation. The patent he holds demonstrates his ability to address complex challenges in the industry and contribute to advancements in medical treatments.
Collaborations: During his time at Glenmark Pharmaceuticals Limited, Khan has collaborated with distinguished colleagues such as Shekhar Bhaskar Bhirud and Samir Naik. These partnerships have played a crucial role in refining his ideas and pushing the boundaries of pharmaceutical research.
Conclusion: Mohammad Amjed Khan exemplifies the spirit of innovation through his dedication to pharmaceutical advancements. With a patent that significantly impacts the preparation of ivacaftor, he continues to push the envelope in his field. As part of Glenmark Pharmaceuticals Limited, Khan's work is vital in shaping the future of medicine and improving patient outcomes.
